Role of vasopressin and terlipressin in refractory shock compared to conventional therapy in the neonatal and pediatric population: a systematic review, meta-analysis, and trial sequential analysis

BACKGROUND: Vasopressin (AVP) and terlipressin (TP) have been used as last-line therapy in refractory shock in children. However, the efficacy and safety profiles of AVP and TP have not been determined in pediatric refractory shock of different origins. We aimed to assess the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Masarwa, Reem, Paret, Gideon, Perlman, Amichai, Reif, Shimon, Raccah, Bruria Hirsh, Matok, Ilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217634/
https://www.ncbi.nlm.nih.gov/pubmed/28057037
http://dx.doi.org/10.1186/s13054-016-1589-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217634/
https://www.ncbi.nlm.nih.gov/pubmed/28057037
http://dx.doi.org/10.1186/s13054-016-1589-6

Ejemplares similares